Real-time enrollment status for this systemic lupus erythematosus (sle) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:41 PM UTC
| NCT Number | NCT07328581 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus (SLE) |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 4 sites in the US |
| Sponsor | iCell Gene Therapeutics |
| Last Updated on CT.gov | September 17, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07328581 is currently recruiting participants. This phase2 study for systemic lupus erythematosus (sle) is actively seeking new participants at 4 locations across the United States. The study is sponsored by iCell Gene Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07328581 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07328581 was last updated 3 weeks ago (September 17, 2026). HelloStudys verifies this status automatically.